Jamie Dimon says he still sees a recession on the horizon

Jamie Dimon says he still sees a recession on the horizon


Key Points
  • JPMorgan Chase CEO Jamie Dimon said Wednesday he still believes that the odds of a “soft landing” for the economy are around 35% to 40%, making recession the most likely scenario in his mind.
  • When asked by CNBC’s Leslie Picker if he had changed his view from earlier this year that markets were too optimistic on recession risks, Dimon said the odds were “about the same” as his earlier call.
  • Dimon added he was “a little bit of a skeptic” that the Federal Reserve can bring inflation down to its 2% target because of future spending on the green economy and military.



Source

Under threat from Trump, Wall Street banks wager they can fend off credit card price controls
Finance

Under threat from Trump, Wall Street banks wager they can fend off credit card price controls

Key Points U.S. banks including JPMorgan Chase and Citigroup showed no signs of capitulation to President Donald Trump’s mandate of a 10% cap on credit card interest rates. Five days after the original threat, bankers and their lobbyists told CNBC that they have yet to receive any formal or written guidance from the Trump administration […]

Read More
Airlines to save big money on fuel as new weight loss pills gain popularity, Wall Street says
Finance

Airlines to save big money on fuel as new weight loss pills gain popularity, Wall Street says

Celsopupo | Istock | Getty Images Wall Street is finding an unexpected beneficiary of America’s weight loss boom: airlines. With the first GLP-1 weight loss drug now available in pill form, analysts at Jefferies say broad adoption across society could quietly lower fuel bills — airlines’ single largest cost — and lift earnings for the […]

Read More
Stocks making the biggest moves midday: Biogen, Rivian, Bank of America, Airbnb & more
Finance

Stocks making the biggest moves midday: Biogen, Rivian, Bank of America, Airbnb & more

Check out the companies making headlines in midday trading. Biogen — The biotech’s stock tumbled more than 4% after the company warned it would need to take a $222 million pretax charge in the fourth quarter. The company said the charge, which includes research-and-development expenses and milestone payments, will lower its net income by about […]

Read More